HKD 1.66
(7.1%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 238.02 Million CNY | 80.42% |
2022 | 131.92 Million CNY | 256.25% |
2021 | 37.03 Million CNY | -1.32% |
2020 | 37.52 Million CNY | 21.88% |
2019 | 30.79 Million CNY | 35.78% |
2018 | 22.67 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 224.63 Million CNY | 13.46% |
2024 Q1 | 224.63 Million CNY | -5.63% |
2023 Q4 | 238.02 Million CNY | 4.2% |
2023 FY | 238.02 Million CNY | 80.42% |
2023 Q3 | 228.44 Million CNY | 16.77% |
2023 Q2 | 195.63 Million CNY | 5.25% |
2023 Q1 | 185.87 Million CNY | 40.89% |
2022 Q4 | 131.92 Million CNY | 7.96% |
2022 Q1 | 54.47 Million CNY | 47.09% |
2022 Q2 | 62.62 Million CNY | 14.97% |
2022 FY | 131.92 Million CNY | 256.25% |
2022 Q3 | 122.2 Million CNY | 95.13% |
2021 Q1 | 34.78 Million CNY | -7.31% |
2021 FY | 37.03 Million CNY | -1.32% |
2021 Q2 | 39.71 Million CNY | 14.16% |
2021 Q4 | 37.03 Million CNY | 18.88% |
2021 Q3 | 31.15 Million CNY | -21.56% |
2020 FY | 37.52 Million CNY | 21.88% |
2020 Q4 | 37.52 Million CNY | 0.0% |
2020 Q1 | - CNY | -100.0% |
2019 Q4 | 395.77 Million CNY | 0.0% |
2019 FY | 30.79 Million CNY | 35.78% |
2018 FY | 22.67 Million CNY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -350.235% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 95.987% |